Medicine prices in India are expected to rise by at least 10% due to increasing raw material costs
tarali 
Medicine prices in India are expected to rise by at least 10% due to increasing raw material costs, driven by the West Asia conflict and global shipping disruptions. The government is considering a temporary price hike for essential medicines, including antibiotics and cancer drugs, to offset manufacturing cost increases. The National Pharmaceutical Pricing Authority (NPPA) regulates medicine prices, allowing a 10% annual increase for non-scheduled drugs, while scheduled drugs are tied to the Wholesale Price Index (WPI).
The price hike is attributed to rising costs of active pharmaceutical ingredients (APIs), solvents, and petrochemical-based inputs, with some raw materials increasing by 50-150%. Pharmaceutical companies argue that current prices are unsustainable, potentially leading to supply disruptions .
About The Author
